Acknowledgement
The authors acknowledge the essential contributions of Bruna Shiroka, Blerta Berberi, Bujar Mema, Ilirjan Gjyzari, Spartak Caka, and Adelina Selimaj.
References
- Barouch DH. COVID-19 vaccines: immunity, variants, boosters. N Engl J Med 2022;387:1011-20.
- Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis 2022;22:1293-302.
- Zhang G, Tang T, Chen Y, Huang X, Liang T. mRNA vaccines in disease prevention and treatment. Signal Transduct Target Ther 2023;8:365.
- Chavda VP, Soni S, Vora LK, Soni S, Khadela A, Ajabiya J. mRNA-based vaccines and therapeutics for COVID-19 and future pandemics. Vaccines (Basel) 2022;10:2150.
- Romer D, Jamieson KH. Conspiracy theories as barriers to controlling the spread of COVID-19 in the U.S. Soc Sci Med 2020;263:113356.
- Guetl K, Raggam RB, Gary T. Thrombotic complications after COVID-19 vaccination: diagnosis and treatment options. Biomedicines 2022;10:1246.
- Saure D, O'Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis 2022;22:56-63.
- Voko Z, Kiss Z, Surjan G, et al. Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 Study). Front Immunol 2022;13:919408.
- Dashdorj NJ, Wirz OF, Roltgen K, et al. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. Cell Host Microbe 2021;29:1738-43.
- Barin B, Kasap U, Selcuk F, Volkan E, Uluckan O. Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study. Lancet Microbe 2022;3:e274-83.
- Ng OT, Marimuthu K, Lim N, et al. Analysis of COVID-19 incidence and severity among adults vaccinated with 2-dose mRNA COVID-19 or inactivated SARS-CoV-2 vaccines with and without boosters in Singapore. JAMA Netw Open 2022;5:e2228900.
- Liu Y, Sanchez-Ovando S, Carolan L, et al. Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19. medRxiv [Preprint] 2023 Jun 5. https://doi.org/10.1101/2023.06.02.23290871
- Lasrado N, Barouch DH. SARS-CoV-2 hybrid immunity: the best of both worlds. J Infect Dis 2023;228:1311-3.